-
1
المساهمون: Figueroa, Jair, Huerfano, Manuel, Buitrago-Medina, Daniel-Alejandro
المصدر: Chang C, Chien W, Chung C, Lee J, Hsu S, Chen J. Impact of hemodialysis on the prognosis of multiple myeloma: A nationwide population-based study and single-institute analysis. Oncology Letters. 2018
Berni Wennekers A, Martín Azara M, Dourdil Sahun V, Bergasa Liberal B, Ruiz Laiglesia J, Vernet Perna P et al. Trece tratamientos de la insuficiencia renal aguda secundaria a mieloma múltiple con filtros de high cut off. Nefrología. 2016.
Wirk B. Renal failure in multiple myeloma: a medical emergency. Bone Marrow Transplantation. 2011
Yadav P, Hutchison C, Basnayake K, Stringer S, Jesky M, Fifer L et al. Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysisdependent acute kidney injury. European Journal of Haematology. 2015.
Tsakiris DJ, Stel VS, Finne P, Fraser E, Heaf J, de Meester J, et al. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrology Dialysis Transplantation. 1 de abril de 2010
Hutchison C, Batuman V, Behrens J, Bridoux F, Sirac C, Dispenzieri A et al. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nature Reviews Nephrology. 2011.
Favà A, Fulladosa X, Montero N, Draibe J, Torras J, Gomà M, et al. Treatment of multiple myeloma with renal involvement: the nephrologist’s view. Clinical Kidney Journal. 1 de diciembre de 2018
Leung N, Behrens J. Current Approach to Diagnosis and Management of Acute Renal Failure in Myeloma Patients. Advances in Chronic Kidney Disease. septiembre de 2012
Haynes RJ, Read S, Collins GP, Darby SC, Winearls CG. Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre. Nephrology Dialysis Transplantation. 1 de febrero de 2010
Decourt A, Gondouin B, Delaroziere J, Brunet P, Sallée M, Burtey S et al. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis. Clinical Journal of the American Society of Nephrology. 2016
Korbet S. Multiple Myeloma. Journal of the American Society of Nephrology. 2006
Tapson JS, Mansy H, Wilkinson R. End-stage renal failure due to multiple myelomapoor survival on peritoneal dialysis. Int J Artif . Organs 1988; 11: 39–42
Pozzi C, D'Amico M, Fogazzi GB et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 2003
Goldschmidt H, Lannert H, Bommer J et al. Multiple myeloma and renal failure. Nephrol Dial Transplant 2000
Batuman V, et al. Myeloma light chains are ligands for cubilin (gp280). Am. J. Physiol. 1998
Klassen RB, Allen PL, Batuman V, Crenshaw K, Hammond TG. Light chains are a ligand for megalin. J. Appl. Physiol. 2005.
Li M, Hering-Smith KS, Simon EE, Batuman V. Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol. Dial. Transplant. 2008
Pote A, Zwizinski C, Simon EE, Meleg-Smith S, Batuman V. Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells. Am. J. Kidney Dis. 2000
Sengul S, Zwizinski C, Batuman V. Role of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells. Am. J. Physiol. Renal Physiol. 2003
Sengul S, et al. Endocytosis of light chains induces cytokines through activation of NF-κB in human proximal tubule cells. Kidney Int. 2002
Sanders PW, Herrera GA, Kirk KA, Old CW, Galla JH. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab. Invest. 1991
Drayson M, et al. Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventionaldose chemotherapy in Medical Research Council UK multiple myeloma trials. Blood. 2006
Terpos E, Roodman E, Dimopoulus M. Optimal use of bisphosphonates in patients with multiple myeloma. BLOOD, 25. April 2013
Copyright and License Information. Section 5: dialysis interventions for treatment of AKI. Kidney Int Suppl (2011). Nature, 2012
Ahmad M. Continuous ambulatory peritoneal dialysis in patients with renal failure due to multiple myeloma. International Urology and Nephrology. 2007
Cook M, Hutchison C, Fifer L, Gillmore J, Heyne N, Weisel K et al. High cut-off haemodialysis (HCO-HD) does not improve outcomes in myeloma cast nephropathy: results of European trial of Free Light Chain removal extended haemodialysis in cast nephropathy (EULITE). EHA Learning Center. Cook M. Jun. 2016
Dimopoulos MA, Roussou M, Gavriatopoulou M, et al. Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit. Blood Cancer J. 2017
Sakhuja V, Jha V, Varma S, Joshi K, Gupta K, Sud K et al. Renal involvement in multiple myeloma: a 10-year study. Renal Failure. 2000.
Blade L, Fernández-Llama R, Bosch E, Montoliu J, Lens W, Montoto S, Cases A, Darnell A, Rozman C, Montserrat E: Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med. 1998
Reyes M, Valera A, Frutos A, Ramos B, Ordoñez V, Lopez De Novales E. Supervivencia de pacientes con mieloma tratados con diálisis. Nefrología. 2003
Hsu C, Ordoñez J, Chertow G, Fan D, McCulloch C, Go A. The risk of acute renal failure in patients with chronic kidney disease. Kidney International. 2008
Hutchison C, Bradwell A, Cook M, Basnayake K, Basu S, Harding S et al. Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis. Clinical Journal of the American Society of Nephrology. 2009
Bridoux F, Carron P, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A et al. Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy. JAMA. 2017
Antlanger M, Dust T, Reiter T, Böhm A, Lamm W, Gornicec M et al. Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study. BMC Cancer. 2018
Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosarioمصطلحات موضوعية: Caracterización de lesión renal en pacientes con neoplasias de células plasmáticas, Characterization of kidney injury in patients with plasma cell neoplasms, Factores clínicos de riesgo en pacientes con mieloma múltiple sometidos a diálisis, Renal replacement therapy in patients with plasma cell cancer, Clinical risk factors in dialysis patients with multiple myeloma, Análisis de terapia de reemplazo renal en pacientes con Mieloma múltiple, Analysis of renal replacement therapy in patients with multiple myeloma, Enfermedades, Terapia de reemplazo renal en pacientes con cáncer de las células plasmáticas
وصف الملف: 32 pp.; application/pdf
-
2Dissertation/ Thesis
المساهمون: Figueroa, Jair, Huerfano, Manuel, Buitrago-Medina, Daniel-Alejandro
المصدر: instname:Universidad del Rosario
مصطلحات موضوعية: Terapia de reemplazo renal en pacientes con cáncer de las células plasmáticas, Factores clínicos de riesgo en pacientes con mieloma múltiple sometidos a diálisis, Análisis de terapia de reemplazo renal en pacientes con Mieloma múltiple, Caracterización de lesión renal en pacientes con neoplasias de células plasmáticas, Enfermedades, Renal replacement therapy in patients with plasma cell cancer, Clinical risk factors in dialysis patients with multiple myeloma, Analysis of renal replacement therapy in patients with multiple myeloma, Characterization of kidney injury in patients with plasma cell neoplasms
وصف الملف: application/pdf